TY - JOUR
T1 - Cis interactions in the Irf8 locus regulate stage-dependent enhancer activation
AU - Liu, Tian Tian
AU - Ou, Feiya
AU - Belk, Julia A.
AU - Bagadia, Prachi
AU - Anderson, David A.
AU - Durai, Vivek
AU - Yao, Winnie
AU - Satpathy, Ansuman T.
AU - Murphy, Theresa L.
AU - Murphy, Kenneth M.
N1 - Funding Information:
A.T.S. is a founder of Immunai and Cartography Biosciences and receives research funding from Allogene Therapeutics and Merck Research Laboratories.
Funding Information:
This work is supported by National Institutes of Health grants R01AI150297, R01AI162643, R21AI164142, R21AI163421, and R01CA248919 to K.M.M. A.T.S. is supported by a Lloyd J. Old STAR Award from the Cancer Research Institute and a Pew-Stewart Scholars for Cancer Research Award. We thank J. Michael White at the Department of Pathology and Immunology Transgenic Mouse Core at Washington University in St. Louis, and the Genetic Editing and iPS Cell (GEiC) Center at Washington University in St. Louis for the generation of mouse models. We thank the Genome Technology Access Center at the McDonnell Genome Institute at Washington University School of Medicine for help with genomic analysis. This work benefitted from data assembled by the ImmGen consortium.
Publisher Copyright:
© 2023 Liu et al.
PY - 2023
Y1 - 2023
N2 - Individual elements within a superenhancer can act in a cooperative or temporal manner, but the underlying mechanisms remain obscure. We recently identified an Irf8 superenhancer, within which different elements act at distinct stages of type 1 classical dendritic cell (cDC1) development. The +41-kb Irf8 enhancer is required for precDC1 specification, while the +32-kb Irf8 enhancer acts to support subsequent cDC1 maturation. Here, we found that compound heterozygous Δ32/Δ41 mice, lacking the +32- and +41-kb enhancers on different chromosomes, show normal pre-cDC1 specification but, surprisingly, completely lack mature cDC1 development, suggesting cis dependence of the +32-kb enhancer on the +41-kb enhancer. Transcription of the +32-kb Irf8 enhancer-associated long noncoding RNA (lncRNA) Gm39266 is also dependent on the +41-kb enhancer. However, cDC1 development in mice remained intact when Gm39266 transcripts were eliminated by CRISPR/Cas9-mediated deletion of lncRNA promoters and when transcription across the +32-kb enhancer was blocked by premature polyadenylation. We showed that chromatin accessibility and BATF3 binding at the +32-kb enhancer were dependent on a functional +41-kb enhancer located in cis. Thus, the +41-kb Irf8 enhancer controls the subsequent activation of the +32-kb Irf8 enhancer in a manner that is independent of associated lncRNA transcription.
AB - Individual elements within a superenhancer can act in a cooperative or temporal manner, but the underlying mechanisms remain obscure. We recently identified an Irf8 superenhancer, within which different elements act at distinct stages of type 1 classical dendritic cell (cDC1) development. The +41-kb Irf8 enhancer is required for precDC1 specification, while the +32-kb Irf8 enhancer acts to support subsequent cDC1 maturation. Here, we found that compound heterozygous Δ32/Δ41 mice, lacking the +32- and +41-kb enhancers on different chromosomes, show normal pre-cDC1 specification but, surprisingly, completely lack mature cDC1 development, suggesting cis dependence of the +32-kb enhancer on the +41-kb enhancer. Transcription of the +32-kb Irf8 enhancer-associated long noncoding RNA (lncRNA) Gm39266 is also dependent on the +41-kb enhancer. However, cDC1 development in mice remained intact when Gm39266 transcripts were eliminated by CRISPR/Cas9-mediated deletion of lncRNA promoters and when transcription across the +32-kb enhancer was blocked by premature polyadenylation. We showed that chromatin accessibility and BATF3 binding at the +32-kb enhancer were dependent on a functional +41-kb enhancer located in cis. Thus, the +41-kb Irf8 enhancer controls the subsequent activation of the +32-kb Irf8 enhancer in a manner that is independent of associated lncRNA transcription.
KW - IRF8
KW - dendritic cell development
KW - enhancer cooperation
KW - enhancer-associated lncRNA
KW - superenhancer
UR - http://www.scopus.com/inward/record.url?scp=85153803295&partnerID=8YFLogxK
U2 - 10.1101/gad.350339.122
DO - 10.1101/gad.350339.122
M3 - Article
C2 - 36990511
AN - SCOPUS:85153803295
SN - 0890-9369
VL - 37
SP - 291
EP - 302
JO - Genes and Development
JF - Genes and Development
IS - 7-8
ER -